| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3853439 | Diálisis y Trasplante | 2008 | 5 Pages |
Abstract
Lanthanum carbonate is a new calcium-free phosphate binder, showing high potency and an acceptable safety profile. Monotherapy with fosrenol is recommended because of its demonstrated efficacy as a potent binder. A lower daily tablet burden compared with other phosphate binders may be associated with better long-term treatment compliance.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
VÃctor Manuel Navas-Serrano,